Role of CYP2C9 polymorphism in phenytoin-related metabolic abnormalities and subclinical atherosclerosis in young adult epileptic patients.
about
PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.Genetic Variants Identified from Epilepsy of Unknown Etiology in Chinese Children by Targeted Exome Sequencing.Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.Parameters of metabolic syndrome in Indian children with epilepsy on valproate or phenytoin monotherapy.
P2860
Role of CYP2C9 polymorphism in phenytoin-related metabolic abnormalities and subclinical atherosclerosis in young adult epileptic patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Role of CYP2C9 polymorphism in ...... oung adult epileptic patients.
@en
Role of CYP2C9 polymorphism in ...... oung adult epileptic patients.
@nl
type
label
Role of CYP2C9 polymorphism in ...... oung adult epileptic patients.
@en
Role of CYP2C9 polymorphism in ...... oung adult epileptic patients.
@nl
prefLabel
Role of CYP2C9 polymorphism in ...... oung adult epileptic patients.
@en
Role of CYP2C9 polymorphism in ...... oung adult epileptic patients.
@nl
P2093
P1476
Role of CYP2C9 polymorphism in ...... oung adult epileptic patients.
@en
P2093
Kanitpong Phabphal
Kitti Limapichart
Pornchai Sathirapanya
Suwanna Setthawatcharawanich
P304
P356
10.1016/J.SEIZURE.2012.10.013
P50
P577
2012-11-16T00:00:00Z